• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies.输血医学中新型病原体的威胁:利用病原体灭活技术提高安全性与可信度
Pathogens. 2023 Jul 5;12(7):911. doi: 10.3390/pathogens12070911.
2
Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light.利用核黄素和紫外线减少血浆和全血中的猴痘病毒。
PLoS One. 2023 Jan 20;18(1):e0278862. doi: 10.1371/journal.pone.0278862. eCollection 2023.
3
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
4
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.使用核黄素和紫外线光对血小板、血浆和全血进行病原体灭活技术处理
Transfus Med Hemother. 2011;38(1):8-18. doi: 10.1159/000324160. Epub 2011 Jan 31.
5
Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.核黄素和紫外线用于血液制品中鼠巨细胞病毒的病原体灭活
Transfusion. 2015 Apr;55(4):858-63. doi: 10.1111/trf.12945. Epub 2014 Dec 1.
6
Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.采用基于核黄素的病原体减少技术提高全血衍生输血产品的安全性。
Blood Transfus. 2017 Jul;15(4):357-364. doi: 10.2450/2017.0320-16. Epub 2017 May 11.
7
Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections.输血传播感染性疾病的当前观点:新出现和再出现的感染
ISBT Sci Ser. 2014 Jul;9(1):30-36. doi: 10.1111/voxs.12070. Epub 2014 Jul 28.
8
[Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].[单供体(单采)血小板与混合全血来源血小板——两种血液制品的意义及评估]
Clin Lab. 2014;60(4):S1-39. doi: 10.7754/clin.lab.2014.140210.
9
The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.核黄素和紫外线对虫媒病毒感染性的影响。
Transfusion. 2015 Apr;55(4):824-31. doi: 10.1111/trf.12899. Epub 2014 Nov 5.
10
Pathogen-reduction systems for blood components: the current position and future trends.血液成分的病原体灭活系统:现状与未来趋势
Transfus Apher Sci. 2006 Dec;35(3):189-96. doi: 10.1016/j.transci.2006.10.002. Epub 2006 Nov 15.

引用本文的文献

1
Navigating converging pathways of co-infection: an integrated epidemiological insight into hepatitis B and malaria among pregnant women in the middle belt of Ghana.探索合并感染的交汇途径:对加纳中部地区孕妇中乙型肝炎和疟疾的综合流行病学洞察
BMC Infect Dis. 2025 Jun 2;25(1):781. doi: 10.1186/s12879-025-11177-x.
2
The Preclinical Validation of 405 nm Light Parasiticidal Efficacy on in Ex Vivo Platelets in a Rag2 Mouse Model.405纳米光对Rag2小鼠模型离体血小板的杀寄生虫效力的临床前验证
Microorganisms. 2024 Jan 29;12(2):280. doi: 10.3390/microorganisms12020280.

本文引用的文献

1
The Evolution of the Safety of Plasma Products from Pathogen Transmission-A Continuing Narrative.血浆制品病原体传播安全性的演变——持续的叙述
Pathogens. 2023 Feb 15;12(2):318. doi: 10.3390/pathogens12020318.
2
A case of occupational transmission of mpox.一例猴痘职业传播病例。
Infection. 2023 Aug;51(4):1169-1173. doi: 10.1007/s15010-023-01989-x. Epub 2023 Feb 3.
3
Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light.利用核黄素和紫外线减少血浆和全血中的猴痘病毒。
PLoS One. 2023 Jan 20;18(1):e0278862. doi: 10.1371/journal.pone.0278862. eCollection 2023.
4
Monkeypox Outbreak 2022: Clinical and Virological Features of 30 Patients at the Sexually Transmitted Diseases Centre of Sant' Orsola Hospital, Bologna, Northeastern Italy.2022 年猴痘疫情:意大利东北部博洛尼亚圣奥尔索拉医院性传播疾病中心 30 例患者的临床和病毒学特征。
J Clin Microbiol. 2023 Jan 26;61(1):e0136522. doi: 10.1128/jcm.01365-22. Epub 2023 Jan 4.
5
Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and .过去 25 年来瑞士在 HIV、HCV、HBV 和. 方面的血液安全演变。
Viruses. 2022 Nov 23;14(12):2611. doi: 10.3390/v14122611.
6
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.猴痘感染患者的病毒动力学:西班牙的一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):445-453. doi: 10.1016/S1473-3099(22)00794-0. Epub 2022 Dec 12.
7
Monkeypox Disease: An Emerging Public Health Concern in the Shadow of COVID-19 Pandemic: An Update.猴痘疾病:新冠疫情阴影下一个新出现的公共卫生问题:最新情况
Trop Med Infect Dis. 2022 Oct 3;7(10):283. doi: 10.3390/tropicalmed7100283.
8
Persistence of monkeypox virus DNA in clinical specimens.猴痘病毒DNA在临床标本中的持续性。
J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.013. Epub 2022 Oct 17.
9
Monkeypox Virus Infection Resulting from an Occupational Needlestick - Florida, 2022.2022 年佛罗里达州一起职业性针刺伤导致感染猴痘病毒。
MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1348-1349. doi: 10.15585/mmwr.mm7142e2.
10
Transfusion-transmitted arboviruses: Update and systematic review.经输血传播的虫媒病毒:最新进展和系统评价。
PLoS Negl Trop Dis. 2022 Oct 6;16(10):e0010843. doi: 10.1371/journal.pntd.0010843. eCollection 2022 Oct.

输血医学中新型病原体的威胁:利用病原体灭活技术提高安全性与可信度

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies.

作者信息

Cardoso Marcia, Ragan Izabela, Hartson Lindsay, Goodrich Raymond P

机构信息

Terumo BCT, Inc., TERUMO Böood and Cell Technologies, Zaventem, 41 1930 Brussels, Belgium.

Infectious Disease Research Center, Department of Biomedical Science, Colorado State University, Fort Collins, CO 80521, USA.

出版信息

Pathogens. 2023 Jul 5;12(7):911. doi: 10.3390/pathogens12070911.

DOI:10.3390/pathogens12070911
PMID:37513758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10383627/
Abstract

Emerging infectious disease threats are becoming more frequent due to various social, political, and geographical pressures, including increased human-animal contact, global trade, transportation, and changing climate conditions. Since blood products for transfusion are derived from donated blood from the general population, emerging agents spread by blood contact or the transfusion of blood products are also a potential risk. Blood transfusions are essential in treating patients with anemia, blood loss, and other medical conditions. However, these lifesaving procedures can contribute to infectious disease transmission, particularly to vulnerable populations. New methods have been implemented on a global basis for the prevention of transfusion transmissions via plasma, platelets, and whole blood products. Implementing proactive pathogen reduction methods may reduce the likelihood of disease transmission via blood transfusions, even for newly emerging agents whose transmissibility and susceptibility are still being evaluated as they emerge. In this review, we consider the Mirasol PRT system for blood safety, which is based on a photochemical method involving riboflavin and UV light. We provide examples of how emerging threats, such as Ebola, SARS-CoV-2, hepatitis E, mpox and other agents, have been evaluated in real time regarding effectiveness of this method in reducing the likelihood of disease transmission via transfusions.

摘要

由于各种社会、政治和地理压力,包括人与动物接触增加、全球贸易、运输以及气候变化,新出现的传染病威胁正变得越来越频繁。由于用于输血的血液制品来自普通人群的献血,通过血液接触或输血传播的新病原体也是一种潜在风险。输血对于治疗贫血、失血和其他病症的患者至关重要。然而,这些挽救生命的程序可能会导致传染病传播,尤其是对弱势群体。全球已实施了新方法来预防通过血浆、血小板和全血制品进行的输血传播。实施积极的病原体灭活方法可能会降低通过输血传播疾病的可能性,即使对于那些其传播性和易感性在出现时尚在评估的新出现病原体也是如此。在本综述中,我们考虑用于血液安全的Mirasol病原体灭活系统,该系统基于一种涉及核黄素和紫外线的光化学方法。我们提供了一些实例,说明如何实时评估埃博拉、SARS-CoV-2、戊型肝炎、猴痘和其他病原体等新出现的威胁在降低通过输血传播疾病可能性方面该方法的有效性。